Sign in to view content

Effect of 6 month anti-VEGF treatment for proliferative diabetic retinopathy on the quantitative metrics of the retinal microvasculature on OCTA

Quan V. Hoang, MD, PhD

Video
Published 2019

Related

Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept
Mark R. Barakat, MD
Annual Meeting Talks
2022
Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy
Milam A. Brantley, MD, PhD
On Demand Cases, Courses, and Papers
2019
VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more